Page last updated: 2024-10-28

hydroxychloroquine and Tachycardia, Ventricular

hydroxychloroquine has been researched along with Tachycardia, Ventricular in 4 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"The incidence and nature of arrhythmias in the setting of COVID-19 were poorly documented across studies."2.72Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review. ( Amarasekera, AT; Kayes, T; Kodsi, M; MacIntyre, CR; Malaty, M; Tan, TC, 2021)
"Quick treatment of hypotension, gastric decontamination, continuous long-term cardiac monitoring, and treatment of arrhythmias are the cornerstones of hydroxychloroquine overdose management."1.32Massive hydroxychloroquine overdose. ( Aksay, E; Atilla, R; Demir, OF; Yanturali, S, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Braunstein, ED3
Olshan, DS3
Gabriels, JK3
Shaikh, Z3
Lerman, BB3
Cheung, JW3
Jacquet-Lagrèze, M1
Riad, Z1
Hugon-Vallet, E1
Ferraris, A1
Fellahi, JL1
Malaty, M1
Kayes, T1
Amarasekera, AT1
Kodsi, M1
MacIntyre, CR1
Tan, TC1
Yanturali, S1
Aksay, E1
Demir, OF1
Atilla, R1

Reviews

2 reviews available for hydroxychloroquine and Tachycardia, Ventricular

ArticleYear
Left ventricular dysfunction in COVID-19: A diagnostic issue.
    Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3

    Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro

2020
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.
    European journal of clinical investigation, 2021, Volume: 51, Issue:2

    Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Atrial Fibrillat

2021

Other Studies

2 other studies available for hydroxychloroquine and Tachycardia, Ventricular

ArticleYear
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia.
    JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:11

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Heart Ventricles; Humans; Hydroxychloroquine; Tachycardia, V

2022
Massive hydroxychloroquine overdose.
    Acta anaesthesiologica Scandinavica, 2004, Volume: 48, Issue:3

    Topics: Adolescent; Antirheumatic Agents; Charcoal; Drug Overdose; Electric Countershock; Female; Gastric La

2004